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Original Article
Impact of cardiac- and noncardiac-related
conditions on adverse outcomes in patients
hospitalized with acute
myocardial infarction
Mayra Tisminetzky1,2,3 , Jerry H Gurwitz1,2,3, Ruben Miozzo4,
Joel M Gore3, Darleen Lessard3, Jorge Yarzebski3
and Robert J Goldberg1,3
Abstract
Background: To examine the impact of cardiac- and noncardiac-related conditions on the risk of hospital complications
and 7- and 30-day rehospitalizations in older adult patients with an acute myocardial infarction (AMI).
Methods and Results: The study population consisted of 3863 adults aged 65 years and older hospitalized with AMI in
Worcester, Massachusetts, during six annual periods between 2001 and 2011. Individuals were categorized into four
groups based on the presence of 11 previously diagnosed cardiac and noncardiac conditions. The median age of the study
population was 79 years and 49% were men. Twenty-eight percent of patients had two or less cardiac- and no noncardiac-
related conditions, 21% had two or less cardiac and one or more noncardiac conditions, 20% had three or more cardiac
and no noncardiac conditions, and 31% had three or more cardiac and one or more noncardiac conditions. Individuals
who presented with one or more noncardiac-related conditions were less likely to have been prescribed evidence-based
medications and/or to have undergone coronary revascularization procedures than patients without any noncardiac
condition. After multivariable adjustment, individuals with three or more cardiac and one or more noncardiac conditions
were at greatest risk for all adverse outcomes.
Conclusions: Older patients hospitalized with AMI carry a significant burden of cardiac- and noncardiac-related con-
ditions. Older adults who presented with multiple cardiac and noncardiac conditions experienced the worse short-term
outcomes and treatment strategies should be developed to improve their in-hospital and post-discharge care and
outcomes.
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Introduction
Cardiovascular disease (CVD) adversely impacts patient’s
quality of life and is the leading cause of morbidity and
mortality in American adults.1 As the US population con-
tinues to age, the prevalence of CVD has correspondingly
increased, together with other chronic conditions.2–4 There
is increasing recognition that individuals with CVD and
multiple chronic conditions (MCCs) experience higher
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levels of health-care use and poorer outcomes than patients
without MCCs.4–10 Despite the high prevalence of MCCs
in patients with CVD, there remains uncertainty as to how
different combinations and burdens of cardiac and noncar-
diac conditions impact their in-hospital and post-discharge
outcomes, especially in older adults aged 65 years
and older.
There is considerable heterogeneity with existing mea-
sures of MCCs and none of these are considered to repre-
sent a gold standard of disease classification. Some
examples of the most commonly used measures include the
Charlson and Elixhauser indices, and simple unweighted
counts of diagnoses of chronic conditions.9–11 Since clin-
icians treat individual patients and not measures of
MCCs,12 clinicians need simple and efficient approaches/
methodologies on how to best assess, manage, and inter-
vene in patients with MCCs and enhance the short- and
long-term outcomes of this vulnerable population.
The two major objectives of this large observational
study were to (1) describe the magnitude of previously
diagnosed cardiac- and noncardiac-related conditions, and
hospital management practices, among older adults hospi-
talized with an independently validated acute myocardial
infarction (AMI); and (2) examine the association between
the burden of cardiac and noncardiac conditions and the
occurrence of clinically significant in-hospital complica-
tions and being readmitted to the hospital. Our overarching
study hypothesis was that older adults hospitalized with
AMI who present with a greater burden of cardiac and
noncardiac conditions will be at greater risk for adverse
outcomes than those with a lower burden of previously
diagnosed chronic conditions. A secondary hypothesis was
that patients who presented with one or more noncardiac
conditions, in addition to the cardiac-related conditions
examined, would be at increased risk for developing
adverse outcomes as compared with those who presented
with only cardiac-related conditions. Data from the Wor-
cester Heart Attack Study were used for purposes of this
investigation.13–16
Methods
The Worcester Heart Attack Study is an ongoing
population-based investigation that is examining long-
term trends in the clinical epidemiology of AMI among
residents of the Worcester, Massachusetts, metropolitan
area hospitalized at all medical centers in Central Massa-
chusetts on an approximate biennial basis.13–17
Computerized printouts of residents of Central Massa-
chusetts admitted to the three largest teaching and commu-
nity hospitals in the city of Worcester with possible AMI
(International Classification of Disease (ICD, see Appen-
dix) 9 codes 410–414, and 786.5) on a biennial basis
between 2001 and 2011 were identified. Cases of possible
AMI were independently validated using predefined cri-
teria for AMI, including diagnoses of ST segment elevation
myocardial infarction (STEMI) and non-ST segment ele-
vation myocardial infarction (NSTEMI).18,19 This study
was approved by the Institutional Review Board at the
University of Massachusetts Medical School.
Trained nurses and physicians abstracted information on
patient’s demographic and clinical characteristics, hospital
treatment practices, and short-term outcomes through the
review of hospital medical records. These characteristics
included patient’s age, sex, race/ethnicity, hospital length
of stay, and 11 previously diagnosed chronic conditions.
These 11 previously diagnosed chronic conditions were
selected based on their high prevalence in our study cohort.
These conditions were defined as those with a frequency
equal to or greater than 3% and were further classified into
two groups20–22; seven cardiac-related conditions: atrial
fibrillation, diabetes mellitus, heart failure, hyperlipidemia,
hypertension, myocardial infarction, and stroke, and four
noncardiac-related conditions: anemia, asthma/chronic pul-
monary disease, chronic kidney disease (CKD), and
depression. Information on the development of clinically
significant in-hospital complications including atrial fibril-
lation,23 cardiogenic shock,24 heart failure,25 stroke,26 and
dying was collected through the review of hospital medical
records. Data on the receipt of three coronary diagnostic
and interventional procedures (cardiac catheterization, per-
cutaneous coronary intervention (PCI), and coronary artery
bypass graft surgery (CABG)) during hospitalization, and
evidence-based pharmacotherapies during hospitaliza-
tion,19,27,28 namely angiotensin converting enzyme inhibi-
tors (ACE-I)/angiotensin receptor blockers (ARBs),
aspirin, beta-blockers, and lipid-lowering agents, were also
collected.
For the present study, a rehospitalization was defined as
the patient’s first admission to a study hospital for any
reason within 7 or 30 days of discharge after their index
hospitalization for AMI during the years under study. Two
of the study investigators adjudicated whether the principal
reason for readmission was due to either an AMI, CVD
(excluding AMI)-related, or non-CVD-related readmission
based on the review of information contained in hospital
medical records. For the present investigation, and due to
sample size limitations and ease of data interpretation, we
have focused on all-cause hospitalizations. The composite
endpoint was defined as the risk of dying or developing any
of the examined important clinical complications (heart
failure, stroke, cardiogenic shock, or atrial fibrillation) dur-
ing hospitalization for AMI.
Data analysis
Based on the sample distribution, we stratified our study
population into four groups according to the presence of
cardiac- or noncardiac-related conditions for purposes of
analysis, namely those with two or less cardiac- and no
noncardiac-related condition (group 1), two or less cardiac-
and one or more noncardiac-related condition (group 2),
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three or more cardiac- and no noncardiac-related condition
(group 3), and three or more cardiac- and one or more
noncardiac-related conditions (group 4). We compared dif-
ferences in the baseline demographic and clinical charac-
teristics, hospital management practices, and development
of in-hospital complications and post-discharge hospital
readmissions between each of these four groups using 2
tests for categorical variables and the analysis of variance
test for continuous variables.
For purposes of more systematically examining the
association between the number of cardiac and noncardiac
conditions previously diagnosed with the risk of dying in
hospital, developing clinically important in-hospital com-
plications, or being rehospitalized within 7 or 30 days after
the patient’s index hospitalization for AMI, we used logis-
tic regression modeling, adjusting for several potentially
confounding demographic and clinical factors of prognos-
tic importance in these models.29,30 These factors were
chosen based on findings from prior studies and on their
clinical significance. The variables we controlled for
included patient’s age, sex, type of AMI (STEMI vs.
NSTEMI), hospital length of stay, receipt of evidence-
based cardiac medications during the index hospitalization
(ACE-I/ARBs, aspirin, beta-blockers, and lipid-lowering
medications), and the receipt of any of the three coronary
diagnostic and interventional procedures examined (car-
diac catheterization, PCI, and CABG) during the patient’s
index hospitalization for AMI. We performed post hoc
pairwise comparisons with Bonferroni corrections to exam-
ine differences between the four groups included in this
study.
Results
A total of 3863 residents of Central Massachusetts 65 years
and older were hospitalized with an independently vali-
dated AMI at the three largest medical centers in Worce-
ster, Massachusetts, during the six study years between
2001 and 2011. The median age of this patient population
was 79 years and 48.9% were men. The four comparison
groups in our study included 1084 (28%) patients in group
1, 806 (21%) patients in group 2, 784 (20%) patients in
group 3, and 1189 (31%) patients in group 4, respectively.
Baseline patient characteristics according to the
presence of cardiac and noncardiac conditions
Patients in group 2 were the oldest (median age 81 years)
and were more likely to be female as compared with those
in group 1 (Table 1). Patients in group 3 had the lowest
proportion of individuals older than 75 years and had the
second highest prevalence of patients who developed an
NSTEMI as compared with those in group 1 (Table 1).
Patients in group 4 were slightly older and were more likely
to be female as compared with patients in group 1 (Table 1).
Patients in group 4 had the highest prevalence of NSTEMI
as compared to the other three groups and together with
those in group 2 had the longest length of stay as compared
to groups 1 and 3.
Frequency of previously diagnosed chronic conditions
The most prevalent chronic conditions among patients in
group 1 were hypertension (64%), hyperlipidemia (41%),
previous myocardial infarction (25%), and diabetes melli-
tus (11%) (Table 1). Among patients in group 2, the most
Table 1. Patient characteristics according to categories of
cardiac- and noncardiac-related conditions.a
Cardiac-/noncardiac-related conditions
Group 1
(n ¼ 1084)
Group 2
(n ¼ 806)
Group 3
(n ¼ 784)
Group 4
(n ¼ 1189)
Characteristic
Age (years, median) 78 81 78 79b
65–74 34.7 25.7 33.3 28.8b
75–84 37.2 38.6 43.1 41.0b
85 and older 28.1 35.7 23.6 30.2b
Male 51.7 42.8 50.1 49.7b
White race 91.5 93.3 92.2 91.1
NSTEMI 65.0 71.0 76.8 83.1c
Length of stay
(days, median)
4 5 4 5b
Medical history
AMI 24.5 31.3 45.5 55.5c
Anemia 0 21.0 0 30.8c
Atrial fibrillation 6.7 9.1 28.7 32.7c
CKD 0 34.7 0 56.6c
Chronic obstructive
pulmonary disease
0 42.4 0 38.8b
Depression 0 35.6 0 28.9c
Diabetes 10.8 13.7 62.8 62.2c
Heart failure 6.0 13.5 38.4 59.4c
Hyperlipidemia 41.1 32.5 79.9 75.7c
Hypertension 64.0 67.9 95.6 94.1c
Stroke 3.8 4.7 22.5 25.9c
Complications during
hospitalization
Atrial fibrillation 20.9 25.1 29.1 30.8c
Cardiogenic shock 5.4 6.3 6.5 5.9
Heart failure 40.6 51.1 55.2 68.0c
Stroke 1.6 2.5 3.2 2.0
Death 9.1 14.0 11.2 13.9b
Readmission to the
hospital
7 days 4.6 6.5 5.9 6.8
30 days 14.5 15.8 17.1 21.5
NSTEMI: non-ST segment elevation myocardial infarction; AMI: acute
myocardial infarction; CKD: chronic kidney disease.
aGroup 1: two or less cardiac diseases and no noncardiac disease; group 2:
two or less cardiac diseases and one or more noncardiac disease; group
3: three or more cardiac diseases and no noncardiac disease; and group 4:
three or more cardiac diseases and one or more noncardiac disease.
bp < 0.01.
cp < 0.001.
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prevalent conditions were hypertension (68%), chronic pul-
monary disease (42%), depression (36%), and CKD (35%)
(Table 1). For those in group 3, the most prevalent condi-
tions were hypertension (96%), hyperlipidemia (80%), dia-
betes mellitus (63%), and previous myocardial infarction
(45%) (Table 1). Among patients in group 4, the most pre-
valent conditions were hypertension (94%), hyperlipidemia
(76%), diabetes mellitus (62%), and heart failure (59%)
(Table 1).
In-hospital clinical complications
In the overall study population, heart failure and atrial
fibrillation were the most common hospital clinical
complications, with the highest incidence in group 4.
Approximately one in every two patients, and one in
every four patients in group 2, developed heart failure
and atrial fibrillation, respectively (Table 1). Similarly,
approximately one in every two patients, and one in
every three patients in group 3, developed heart failure
and atrial fibrillation, respectively, during their index
hospitalization (Table 1). Patients in group 4 were at
the greatest risk for developing heart failure (68%) and
atrial fibrillation (31%) during their index hospitaliza-
tion for AMI. Groups 2 and 4 had the highest death rate
as compared with the other two groups.
Hospital management practices
Patients in group 2 had the lowest proportion of individuals
who were treated with ACE-I/ARBs as compared with
patients in the other three groups. Patients in group 3 were
more likely to have been treated with ACE-I/ARBs and
lipid-lowering medications as compared with patients in
group 1. Patients in group 4, together with those in group
2, were slightly less likely to have been treated with aspirin
and beta-blockers during their acute hospitalization as com-
pared with patients in the other two groups (Table 2).
The proportion of patients in groups 2 and 4 who received
any diagnostic/interventional procedure was significantly
lower as comparedwith the other twopatient groups (Table 2).
Risk of adverse hospital and post-discharge outcomes
After controlling for several potentially confounding
demographic and clinical factors of prognostic importance,
patients in groups 2, 3, and 4 had an increased risk of dying
during hospitalization as compared with those in group 1;
the greatest risk for dying was observed among patients in
group 4 (Table 3). After performing pairwise comparisons
with Bonferroni corrections, these important differences
were statistically significant between group 2 and group 1
and between group 4 and group 1 (p < 0.05).
The risk of developing any clinically significant in-
hospital complication was increased across all comparison
groups, with an increasing trend from group 2 through
group 4 (Table 3). After running pairwise comparisons with
Bonferroni corrections, our findings suggest that these
comparisons were statistically significant between group
2 and group 1, group 3 and group 1, group 4 and group
1, group 4 and group 2, and for patients in group 4 and
group 3 (p < 0.05).
The risk for being readmitted to the hospital within 7 days
after the patient’s index hospitalization for AMI, according
to the presence of cardiac and noncardiac conditions, was
slightly higher during this period among patients in groups 2
and 4 as compared with those in group 1, with the highest risk
of being readmitted during the subsequent 7 days noted for
patients in group 4. Similar trends were found with regard to
the risk of readmission within 30 days, with the highest risk
noted among patients in group 4 (Table 3). After running pair-
wise comparisons with Bonferroni corrections, there were no
differences between groups in the risk of having a 7-day read-
mission. On the other hand, when examining 30-day readmis-
sions, the comparisons were statistically significant between
group 3 and group 1 and group 4 and group 1 (p < 0.05).
Discussion
In this investigation of more than 3800 patients 65 years
and older hospitalized with a confirmed AMI at the
three largest tertiary care and community medical cen-
ters in Central Massachusetts between 2001 and 2011,
Table 2. Clinical management during hospitalization for AMI
according to categories of cardiac- and noncardiac-related
conditions.a
Cardiac-/noncardiac-related conditions
Group 1
(n ¼ 1084)
Group 2
(n ¼ 806)
Group 3
(n ¼ 784)
Group 4
(n ¼ 1189)
Diagnostic/interventional
procedure
Cardiac
catheterization
59.9 41.7 56.6 42.2b
Coronary artery
bypass surgery
7.7 4.5 7.0 4.8c
PCI 42.5 27.7 35.7 23.9b
Medications
ACE-I/ARBs 65.1 58.8 74.0 68.1b
Aspirin 92.8 90.0 92.6 90.2c
Beta-blockers 90.5 86.1 90.1 89.6c
Lipid-lowering
medications
70.5 63.2 77.9 75.3b
AMI: acute myocardial infarction; PCI: percutaneous coronary interven-
tion; ACE-I: angiotensin converting enzyme inhibitors; ARBs: angiotensin
receptor blockers.
aGroup 1: two or less cardiac diseases and no noncardiac disease; group 2:
two or less cardiac diseases and one or more noncardiac disease; group
3: three or more cardiac diseases and no noncardiac disease; and group 4:
three or more cardiac diseases and one or more noncardiac disease.
bp < 0.001.
cp < 0.01.
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patients presented to these hospitals with a considerable
burden of cardiac- and noncardiac-related conditions.
Moreover, after multivariable adjustment, patients in
group 4 (those with the greatest burden of MCCs) had a
greater risk for developing each of the adverse outcomes
examined compared with patients in the other three
groups. Of note, our findings suggest that individuals who
presented with a higher burden of cardiac- and noncardiac-
related conditions were at greater risk for dying or devel-
oping clinically significant complications during their
index admission for AMI whereas individuals who pre-
sented with any noncardiac-related conditions were at a
slightly higher risk of being readmitted to the hospital
within 7 days of their index AMI event.
Frequency of individual chronic conditions
Among patients in group 4 (31% of the study cohort),
hypertension, hyperlipidemia, diabetes, heart failure, and
CKD were highly prevalent; a relatively similar profile of
these conditions was observed among patients in group 2
though these individuals also presented with a high preva-
lence of chronic pulmonary disease and depression.
Our findings share similar patterns to the results of a
previous analysis from the Worcester Heart Attack
Study which showed a high prevalence of hypertension
and diabetes among patients with two or more cardiac
comorbidities while the most prevalent noncardiac-
related condition was CKD.31 The present results are
also consistent with findings from other contemporary
investigations that have studied patients hospitalized
with AMI, including a community-based study from
Kaiser Permanente Northern California that demon-
strated a high burden of hypertension and diabetes in
this large HMO population.32
Differences in hospital management practices
according to the presence of previously diagnosed
cardiac and noncardiac conditions
We observed relatively small differences across the four
groups with regard to the prescribing of in-hospital cardiac
medications. Clinical trials of treatments for CVD have
usually excluded older adults with a high burden of multi-
morbidity, which has led to evidence gaps in how to best
treat this medically complex, vulnerable population.10 We
also found that patients in groups 2 and 4, who were
slightly older and sicker than the other comparison groups,
were less likely to have undergone coronary revasculariza-
tion procedures. Thus, there is a clear need for developing
evidence-based data to help clinicians care for this group of
patients given their MCCs and high risk for adverse clinical
outcomes.
Table 3. Crude and multivariable adjusted risk of adverse events according to categories of cardiac- and noncardiac-related
conditions.a
Cardiac-/noncardiac-related conditions
Adverse events Group 1 (n ¼ 1084) Group 2 (n ¼ 806) Group 3 (n ¼ 784) Group 4 (n ¼ 1189)
In-hospital death OR 95% CI
Unadjusted model Reference 1.62 (1.22; 2.16) 1.26 (0.93; 1.70) 1.60 (1.23; 2.09)
Adjusted by age and sex model Reference 1.53 (1.13; 2.06) 1.26 (0.92; 1.72) 1.52 (1.15; 1.99)
Full adjusted model Reference 1.31 (0.95; 1.81) 1.59 (1.14; 2.22) 1.78 (1.32; 2.39)
Composite outcome
Unadjusted model Reference 1.53 (1.27; 1.84) 1.81 (1.50; 2.17) 3.10 (2.61; 3.69)
Adjusted by age and sex model Reference 1.56 (1.28; 1.89) 1.94 (1.60; 2.36) 3.32 (2.77; 3.97)
Full adjusted model Reference 1.43 (1.17; 1.75) 1.81 (1.48; 2.21) 2.82 (2.33; 3.42)
7-day any cause rehospitalization OR 95% CI
Unadjusted model Reference 1.49 (0.99; 2.22) 1.32 (0.88; 2.00) 1.58 (1.10; 2.28)
Adjusted by age and sex model Reference 1.44 (0.95; 2.19) 1.31 (0.86; 2.00) 1.56 (1.07; 2.26)
Full adjusted model Reference 1.49 (0.98; 2.27) 1.32 (0.86; 2.01) 1.62 (1.10; 2.37)
30-day any cause rehospitalization OR 95% CI
Unadjusted model Reference 1.17 (0.91; 1.52) 1.26 (0.97; 1.62) 1.75 (1.40; 2.18)
Adjusted by age and sex model Reference 1.15 (0.88; 1.51) 1.23 (0.95; 1.60) 1.74 (1.38; 2.18)
Full adjusted model Reference 1.14 (0.87; 1.50) 1.18 (0.91; 1.54) 1.67 (1.32; 2.11)
CI: confidence interval; NSTEMI: non-ST segment elevation myocardial infarction; AMI: acute myocardial infarction; STEMI: ST segment elevation
myocardial infarction; PCI: percutaneous coronary intervention; ACE-I: angiotensin converting enzyme inhibitors; ARBs: angiotensin receptor blockers;
CABG: coronary artery bypass graft surgery.
aFully adjusted models controlled for age, sex, type of AMI (STEMI/NSTEMI), length of stay, receipt of any of the four medications examined (ACE-I/
ARBs, aspirin, beta-blockers, and lipid-lowering medications), and the receipt of any of the three coronary diagnostic and interventional procedures
(cardiac catheterization, PCI, and CABG) during the index hospitalization for AMI. Group 1: two or less cardiac diseases and no noncardiac disease;
group 2: two or less cardiac diseases and one or more noncardiac disease; group 3: three or more cardiac diseases and no noncardiac disease; and group
4: three or more cardiac diseases and one or more noncardiac disease.
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Risk of adverse hospital outcomes according to the
presence of previously diagnosed cardiac and
noncardiac conditions
The individual effects of cardiac- and noncardiac-related
conditions on in-hospital complications and 7- and 30-day
rehospitalizations in individuals hospitalized with AMI
have been studied in a number of prior investiga-
tions.5,9,31,33 In a large study in two major hospitals in
Spain of more than 5000 patients hospitalized with AMI
between 2003 and 2009, those who presented with heart
failure and/or various cardiac arrhythmias were at higher
risk for dying during their index hospital admission as
compared to those without these chronic conditions.33 In
a prior publication from the Worcester Heart Attack Study,
patients with an increasing number of cardiac-related con-
ditions were at greater risk for dying at 30 days and 1 year
than those with none or one previously diagnosed cardiac
condition.9
Patients with noncardiac-related conditions have also
been shown to be at increased risk for developing adverse
outcomes in persons hospitalized with AMI, including
patients previously studied in the Worcester Heart Attack
Study.31 Similarly, in a prior publication from the Worce-
ster Heart Attack Study, patients presenting with noncar-
diac-related conditions were at increased risk for
developing adverse outcomes during the index hospitaliza-
tion for AMI. In a study of more than 3900 patients admit-
ted with AMI to 19 US medical centers between 2003 and
2004, the presence of any noncardiac condition was asso-
ciated with a five times greater risk of dying during hospi-
talization as compared to those without any noncardiac
condition.5
The combined effects of cardiac- and noncardiac-related
conditions on short-term hospital and post-discharge out-
comes in individuals hospitalized with AMI are less well
known. In our study of Central Massachusetts residents
hospitalized with AMI, individuals who presented with
three or more cardiac- and one or more noncardiac-
related condition were at the greatest risk for dying during
their acute hospitalization, developing clinically significant
complications, and for being rehospitalized during the next
30 days. The Swiss AMIS Plus registry of more than 29,600
patients with an acute coronary syndrome examined the
burden of multimorbidity, as assessed by the Charlson
Comorbidity Index, in relation to the risk of dying during
the patient’s index hospitalization. The study investigators
reported a two times greater risk of dying during the index
hospitalization in individuals with three or more chronic
conditions as compared to those without any of the exam-
ined chronic conditions.34 A study of more than 3000
patients who were hospitalized in Olmsted County, Minne-
sota, with a first-ever AMI between 1987 and 2010 and
who presented with diabetes, chronic obstructive pulmon-
ary disease, or anemia were at higher risk for being read-
mitted to the hospital within 30 days as compared to those
without these chronic conditions. In a study of more than
3000 patients admitted to the hospital with an incident AMI
in Olmsted County, Minnesota, between 1987 and 2010,
researchers reported that the presence of diabetes, chronic
pulmonary disease or anemia was associated with higher
risk for being readmitted to the hospital within 30 days as
compared to those without these chronic conditions.35
We found that individuals with one or more noncardiac-
related condition (groups 2 and 4), in addition to any car-
diac condition, experienced a slightly higher risk of being
rehospitalized over the subsequent 7 days as compared with
patients in group 1. These findings provide further suppor-
tive evidence that the presence of noncardiac-related con-
ditions including CKD, chronic pulmonary disease,
anemia, and depression should be carefully considered and
monitored when managing patients recently admitted to the
hospital with an AMI.
Clinical implications
The present study expands upon previous work by studying
not only the individual but also the combined effects of
several previously diagnosed cardiac and noncardiac con-
ditions in patients hospitalized with an AMI. Our results
indicate that cardiac and noncardiac conditions are
common in individuals hospitalized with AMI and have
important prognostic implications. The presence of these
cardiac- and noncardiac-related conditions increases the
challenges for health-care providers due to the complexity
of the interaction between diseases, diseases and medical
treatments, and between various cardiac and noncardiac
medications.25 Since clinical guidelines and disease man-
agement programs typically focus on patients with single
conditions, and clinical research often excludes persons with
MCCs, our observation that patients with several cardiac or
noncardiac conditions were significantly more likely to have
experienced adverse hospital and post-discharge outcomes
suggests that current clinical guidelines need to take into
consideration these high-risk patients.
Study strengths and limitations
The strengths of the present study include its community-
based design, its large sample of patients hospitalized with
AMI, and its relatively contemporary perspective in exam-
ining clinically relevant outcomes and hospital treatment
practices according to the frequency of a number of impor-
tant cardiac and noncardiac conditions. There was compre-
hensive ascertainment of cardiac- and noncardiac-related
conditions, death, in-hospital complications, and post-
discharge hospitalizations. Several limitations need to be
acknowledged, however, in the interpretation of the present
findings. First, since our study population included only
patients who had been hospitalized in the Worcester met-
ropolitan area, one needs to be careful to extrapolate our
findings to those who reside in other geographic areas.
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Second, since the majority of the study patients were
White, the generalizability of our findings to other race/
ethnic groups may be limited. There is the potential for
unmeasured confounding since we did not have informa-
tion available on several patient-associated characteristics,
such as income, education, psychosocial factors, body mass
index, or smoking status, that may have affected several of
the endpoints examined. Finally, detailed information
about the duration or severity of the chronic conditions
studied was unavailable.
Conclusions
The findings of our investigation suggest that cardiac- and
noncardiac-related conditions are highly prevalent in
patients 65 years of age and older hospitalized with AMI
and individuals presenting with both types of chronic con-
ditions are at greatest risk for developing adverse
in-hospital and short-term outcomes. We observed that
individuals who presented with one or more noncardiac-
related condition were less likely to have been prescribed
evidence-based medications and/or undergone coronary
revascularization procedures than patients without any
noncardiac condition. Due to the extremely limited pub-
lished evidence that exists to guide the treatment of this
vulnerable population, there is a clear need for developing
guidelines that might help health-care providers caring for
these patients. Future research should also examine the
impact of cardiac- and noncardiac-related conditions on
important long-term clinical and patient-centered outcomes
in patients hospitalized with AMI that will help clinicians,
caregivers, and patients in discussions about the manage-
ment and prognosis of patients with these chronic
conditions.
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Appendix: ICD-9 Chronic Conditions Codes
Chronic Condition ICD-9
Acute myocardial
infarction
410-414, and 786.5
Anemia 280-285
Atrial fibrillation 427.31; 427.32
Chronic kidney
disease
016.00, 016.01, 016.02, 016.03, 016.04, 016.05, 016.06, 095.4, 189.0, 189.9, 223.0, 236.91, 249.40, 249.41,
250.40, 250.41, 250.42, 250.43, 271.4, 274.10, 283.11, 403.01, 403.11, 403.91, 404.02, 404.03, 404.12,
404.13, 404.92, 404.93, 440.1, 442.1, 572.4, 580.0, 580.4, 580.81, 580.89, 580.9, 581.0, 581.1, 581.2,
581.3, 581.81, 581.89, 581.9, 582.0, 582.1, 582.2, 582.4, 582.81, 582.89, 582.9, 583.0, 583.1, 583.2, 583.4,
583.6, 583.7, 583.81, 583.89, 583.9, 584.5, 584.6, 584.7, 584.8, 584.9, 585.1, 585.2, 585.3, 585.4, 585.5,
585.6, 585.9, 586, 587, 588.0, 588.1, 588.81, 588.89, 588.9, 591, 753.12, 753.13, 753.14, 753.15, 753.16,
753.17, 753.19, 753.20, 753.21, 753.22, 753.23, 753.29, 794.4
Chronic pulmonary
disease
490, 491.0, 491.1, 491.20, 491.21, 491.22, 491.8, 491.9, 492.0, 492.8, 494.0, 494.1, 496
Depression 296.20, 296.21, 296.22, 296.23, 296.24, 296.25, 296.26, 296.30, 296.31, 296.32, 296.33, 296.34, 296.35,
296.36, 296.51, 296.52, 296.53, 296.54, 296.55, 296.56, 296.60, 296.61, 296.62, 296.63, 296.64, 296.65,
296.66, 296.89, 298.0, 300.4, 309.1, 311
Diabetes 249.00, 249.01, 249.10, 249.11, 249.20, 249.21, 249.30, 249.31, 249.40, 249.41, 249.50, 249.51, 249.60,
249.61, 249.70, 249.71, 249.80, 249.81, 249.90, 249.91, 250.00, 250.01, 250.02, 250.03, 250.10, 250.11,
250.12, 250.13, 250.20, 250.21, 250.22, 250.23, 250.30, 250.31, 250.32, 250.33, 250.40, 250.41, 250.42,
250.43, 250.50, 250.51, 250.52, 250.53, 250.60, 250.61, 250.62, 250.63, 250.70, 250.71, 250.72, 250.73,
250.80, 250.81, 250.82, 250.83, 250.90, 250.91, 250.92, 250.93, 357.2, 362.01, 362.02, 362.03, 362.04,
362.05, 362.06, 366.41
Heart Failure 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21,
428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42,
Hyperlipidemia 272.0, 272.1, 272.2, 272.3, 272.4
Hypertension 401.0, 401.1, 401.9, 402.00, 402.01, 402.10, 402.11, 402.90, 402.91, 403.00, 403.01, 403.10, 403.11, 403.90,
403.91, 404.00, 404.01, 404.02, 404.03, 404.10, 404.11, 404.12, 404.13, 404.90, 404.91, 404.92, 404.93,
405.01, 405.09, 405.11, 405.19, 405.91, 405.99, 362.11, 437.2
Stroke/CVA 430, 431, 433.01, 433.11, 433.21, 433.31, 433.81, 433.91,434.00, 434.01,434.10, 434.11, 434.90, 434.91,
435.0, 435.1, 435.3, 435.8, 435.9, 436, 997.02
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